The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu(The University of Texas MD Anderson Cancer Center), Kevin Kelnar(Mirna Therapeutics (United States)), Bigang Liu(The University of Texas MD Anderson Cancer Center), Xin Chen(The University of Texas MD Anderson Cancer Center), Tammy Calhoun‐Davis(The University of Texas MD Anderson Cancer Center), Hangwen Li(The University of Texas MD Anderson Cancer Center), Lubna Patrawala, Hong Yan(The University of Texas MD Anderson Cancer Center), Collene Jeter(The University of Texas MD Anderson Cancer Center), Sofia Honorio(The University of Texas MD Anderson Cancer Center), Jason F. Wiggins(Mirna Therapeutics (United States)), Andreas G. Bader(Mirna Therapeutics (United States)), Randy Fagin, David T. Brown(Mirna Therapeutics (United States)), Dean G. Tang(The University of Texas MD Anderson Cancer Center)
Nature Medicine
January 16, 2011
Cited by 1,404Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis